SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer

Recently, immune checkpoint inhibitors (ICIs), such as programmed cell death 1 (PD-1) monoclonal antibodies (mAbs), have revolutionized the treatment of malignant tumors. Therefore, the number of studies aiming to screen and identify new immune checkpoint molecules for antitumor immunotherapy is inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yaping, Zhang, Qun, Han, Xingzhi, Han, Lu, Wang, Ting, Hu, Jing, Li, Li, Ding, Zhou, Shi, Xiao, Qian, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036734/
https://www.ncbi.nlm.nih.gov/pubmed/36931016
http://dx.doi.org/10.1016/j.tranon.2023.101654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036734/
https://www.ncbi.nlm.nih.gov/pubmed/36931016
http://dx.doi.org/10.1016/j.tranon.2023.101654

Ejemplares similares